XTRA:ADN1IT
Adesso (XTRA:ADN1) Margin Recovery To 1.2% Tests Long Term Bearish Narratives
adesso (XTRA:ADN1) has reported full year 2025 numbers that put revenue and earnings squarely in focus, with Q4 revenue at €411.1 million and basic EPS of €1.81, while trailing 12 month revenue stands at €1.5 billion and EPS at €2.78. Over recent periods, the company has seen quarterly revenue move from €331.7 million in Q3 2024 to €411.1 million in Q4 2025, with basic EPS ranging from a loss of €0.53 in Q1 2025 to €1.81 in Q4 2025 and trailing 12 month net income at €18.1 million. For...